文献速递前列腺癌

PRAGMATIC路径:护士导航员分诊加速前列腺癌诊疗

The PRAGMATIC pathway - PRostate cancer diAGnosis and MAnagement Triage In Clinical care.
PubMed 文献 · BJU Int · 2026-02-26

本研究评估护士导航员主导的分诊系统PRAGMATIC对高危前列腺癌诊断和治疗时间的影响。回顾性分析2022年3个月165例及2024年3个月327例疑似前列腺癌患者,比较分诊前后诊疗时间线。结果显示分诊后转诊至首诊、MRI、活检决策、活检操作、结果沟通及PSMA PET-CT分期扫描的中位时间均显著缩短(均P<0.001),高危患者转诊至治疗时间也缩短(104 vs 70天,P<0.05)。

要点

  • 护士导航员分诊可缩短高危前列腺癌患者影像、活检及治疗等待时间
  • Gleason≥3或T3/N1/M1患者转诊至治疗中位时间由104天降至70天
  • M1b患者转诊至治疗中位时间由47天降至27天

核心结论

  • 护士导航员主导的分诊和分层与最高危疑似前列腺癌患者影像、活检诊断及治疗时间改善相关。

研究设计与样本

  • 回顾性比较研究,比较2022年3个月165例和2024年3个月327例连续疑似前列腺癌患者。
  • 2024年引入护士导航员对紧急转诊进行分诊,基于PSA、MRI分期和组织学快速分流。

主要发现

  • 分诊后转诊至首诊中位时间8天降至4天,MRI 12天降至6天,MRI结果26天降至17天(均P<0.001)。
  • 活检决策25天降至16天,活检操作48天降至22天,活检结果沟通64天降至44天(均P<0.001)。
  • PSMA PET-CT分期扫描87天降至56天(P<0.001)。
  • Gleason分级组≥3或T3或≥N1或≥M1患者转诊至治疗中位时间104天降至70天(P<0.05)。
  • M1b患者转诊至治疗中位时间47天降至27天(P<0.05)。

临床怎么用

  • 对高危疑似前列腺癌患者采用护士导航员分诊可优化诊疗流程并缩短等待时间。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate whether nurse navigator-led triaging of high-risk patients may reduce prostate cancer (PCa) diagnosis and treatment times using an in-house bespoke PRostate cancer diAGnosis and MAnagement Triage In the Clinial care pathway (PRAGMATIC) triaging system, as locally advanced/metastatic disease should be diagnosed and treated rapidly, and UK targets allow 28 days for diagnosis, and 62 days to commence treatment. PATIENTS AND METHODS: We reviewed diagnosis and treatment timelines for patients undergoing 28/62-day investigation for suspected PCa at a tertiary unit in a 3-month period (2022). We then introduced nurse navigator-led triaging of urgent referrals and evaluated a subsequent 3-month period (2024), with streamlining for rapid investigation and treatment based on prostate-specific antigen, magnetic resonance imaging (MRI) staging, and histology. We hypothesised nurse navigator-led triaging would improve investigation and treatment times for high-risk localised, or locally advanced, or metastatic PCa. RESULTS: A total of 165 and 327 consecutive patients were on the 28/62-day PCa pathway in the pre- (2022) and post-nurse navigator-led (2024) triaging periods, respectively. The median time from referral to first appointment (8 vs 4 days), MRI (12 vs 6 days), MRI result (26 vs 17 days), biopsy decision (25 vs 16 days), biopsy procedure (48 vs 22 days), biopsy result communication (64 vs 44 fays), and prostate-specific membrane antigen positron emission tomography computed tomography staging scan (87 vs 56 days) was reduced following nurse navigator triaging of high-risk cases (all P < 0.001). The median time from referral to treatment for Gleason Grade Group ≥3, or T3, or ≥N1, or ≥M1 disease (104 vs 70 days; 49/75 [65.3%] vs 72/128 [56.3%] patients), and for M1b disease (47 vs 27 days; 15/75 [20%] vs 32/128 [25%] patients), was reduced (P < 0.05). CONCLUSIONS: Nurse navigator-led triaging and stratification of the most clinically urgent suspected PCa cases was associated with improved imaging, biopsy diagnosis, and treatment times for the highest-risk patients.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Sharma A, Campbell T, Kanabar S, et al. The PRAGMATIC pathway - PRostate cancer diAGnosis and MAnagement Triage In Clinical care. BJU Int. 2026. PMID: 41744174. doi:10.1111/bju.70191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。